Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | USP2 | O75604 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | CACNA2D1 | P54289 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL625309 | 0.84 | — | — | |
| Cesium SCHEMBL625472 | 0.82 | CYP1A2 (0.45) | CYP1A2TSHRUSP2ALDH1A1LMNA | |
| SCHEMBL626489 | 0.82 | CYP1A2 (0.45) | CYP1A2TSHRUSP2ALDH1A1LMNA | |
| SCHEMBL3226150 | 0.82 | CYP1A2 (0.45) | CYP1A2TSHRUSP2ALDH1A1LMNA | |
| SCHEMBL990885 | 0.82 | CYP1A2 (0.45) | CYP1A2TSHRUSP2ALDH1A1LMNA | |
| Toluene SCHEMBL1205528 | 0.71 | KMT2A (0.47) | TSHRUSP2ALDH1A1LMNASMN1; SMN2 | |
| SCHEMBL6138352 | 0.70 | CYP1A2 (0.42) | CYP1A2TSHRUSP2ALDH1A1LMNA | |
| SCHEMBL9681942 | 0.70 | ALDH1A1 (0.54) | CYP1A2TSHRUSP2ALDH1A1LMNA | |
| SCHEMBL6124890 | 0.69 | — | — | |
| Mercaptopropionic Acid SCHEMBL28208849 | 0.67 | ACE (0.46) | TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100069641-A1 | PROCESS FOR THE PREPARATION OF SODIUM SALT OF 1-(((1(R)-(3-(2-(7-CHLORO-2-QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(1-HYDROXY-1-METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID | ZAKLADY FARMACEUTYCZNE POLPHARMA S.A. (PL) | 2010-03-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100069641-A1 | PROCESS FOR THE PREPARATION OF SODIUM SALT OF 1-(((1(R)-(3-(2-(7-CHLORO-2-QUINOLINYL)-ETHENYL)PHENYL)-3-(2-(1-HYDROXY-1-METHYLETHYL)PHENYL)PROPYL)SULFANYL)METHYL)CYCLOPROPANEACETIC ACID | SLC7A1, CLIC1, TMT1A | CYP1A2 1556/4885TSHR 824/4885USP2 1190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.